4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001567619-20-019923
10% owner bought 476,667 shares at an average $4.76 ($2,270,484)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Logos Global Master Fund LP 10% owner | 2020-11-09 | Purchase | +250,000 | $1.10 | $274,475 | 6,250,000 | D: show line 1 in the form |
| Logos Global Master Fund LP 10% owner | 2020-11-09 | Purchase | +100,000 | $1.16 | $116,410 | 6,350,000 | D: show line 2 in the form |
| Logos Global Master Fund LP 10% owner | 2020-11-13 | Purchase | +126,667 | $14.84 | $1,879,599 | 550,000 | D: show line 3 in the form |
| Open-market purchases · 476,667 sh · avg $4.76 · $2,270,484 | |||||||
Loading xslF345X03/doc1.xml…